KTN3379: Updated Phase I data

Updated data from 38 patients with advanced solid tumors in the 2-part, open-label, U.S. Phase I KTN3379-CL-001 trial

Read the full 183 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE